• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与卡氮芥联合化疗期间的进行性肺纤维化(作者译)

[Progressive pulmonary fibrosis during combination chemotherapy with BCNU (author's transl)].

作者信息

Schreml W, Bargon G, Anger B, Kubanek B, Heimpel H

出版信息

Blut. 1978 Jun 20;36(6):353-6. doi: 10.1007/BF01000593.

DOI:10.1007/BF01000593
PMID:656638
Abstract

In two patients with acute leukaemia, the development of progressive interstitial pulmonary fibrosis was observed following chemotherapy with BCNU, Cytoxan and Ara-C. The x-ray changes were accompanied by restrictive changes of pulmonary function and, later on, by severe hypoxia. Serologic tests did not reveal infection with cytomegaly virus or mycoplasma pneumoniae. These findings, together with reports in the literature, suggest a toxic effect of BCNU on the lung. The combination with Cyclophosphamide may contribute to this toxic reaction.

摘要

在两名急性白血病患者中,观察到在接受卡氮芥、环磷酰胺和阿糖胞苷化疗后出现进行性间质性肺纤维化。X线改变伴有肺功能的限制性改变,随后出现严重缺氧。血清学检查未发现巨细胞病毒或肺炎支原体感染。这些发现以及文献报道提示卡氮芥对肺有毒性作用。与环磷酰胺联合使用可能会导致这种毒性反应。

相似文献

1
[Progressive pulmonary fibrosis during combination chemotherapy with BCNU (author's transl)].与卡氮芥联合化疗期间的进行性肺纤维化(作者译)
Blut. 1978 Jun 20;36(6):353-6. doi: 10.1007/BF01000593.
2
[Progressive pulmonary fibrosis due to combined treatment with BCNU, cyclophosphospahmide and cytosin-arabinoside (author's transl)].因卡氮芥、环磷酰胺和阿糖胞苷联合治疗导致的进行性肺纤维化(作者译)
Rofo. 1978 Sep;129(3):312-6. doi: 10.1055/s-0029-1231036.
3
Pulmonary fibrosis following low-dose 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) therapy.低剂量1,3-双(2-氯乙基)-1-亚硝基脲(卡莫司汀)治疗后发生的肺纤维化
Cancer. 1980 Mar 15;45(6):1311-4. doi: 10.1002/1097-0142(19800315)45:6<1311::aid-cncr2820450607>3.0.co;2-u.
4
Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU).与双氯乙基亚硝脲(BCNU)相关的肺部毒性。
Ann Intern Med. 1979 Feb;90(2):191-4. doi: 10.7326/0003-4819-90-2-191.
5
Proceedings: Combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone, and BCNU.研究报告:美法仑、环磷酰胺、长春新碱、泼尼松和卡氮芥联合化疗多发性骨髓瘤
Cancer. 1974 Feb;33(2):533-8. doi: 10.1002/1097-0142(197402)33:2<533::aid-cncr2820330231>3.0.co;2-z.
6
Remission maintenance of acute nonlymphoblastic leukemia with BCNU (NSC-409962) and cyclophosphamide (NSC-26271).
Cancer Chemother Rep. 1975 May-Jun;59(3):537-45.
7
1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced pulmonary fibrosis.1,3-双(2-氯乙基)-1-亚硝基脲(卡莫司汀)诱导的肺纤维化。
Neurosurgery. 1980 Dec;7(6):560-5. doi: 10.1227/00006123-198012000-00003.
8
Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood.儿童期接受卡莫司汀(BCNU)化疗后长达17年出现的活动性肺纤维化。
N Engl J Med. 1990 Aug 9;323(6):378-82. doi: 10.1056/NEJM199008093230604.
9
Chronic lung fibrosis following carmustine (BCNU) chemotherapy: radiological features.卡莫司汀(BCNU)化疗后慢性肺纤维化:影像学特征
Clin Radiol. 1991 Nov;44(5):299-301. doi: 10.1016/s0009-9260(05)81262-0.
10
Pulmonary fibrosis after prolonged therapy with 1,3-bis (2-chloroethyl)-1-nitrosourea.长期使用1,3 - 双(2 - 氯乙基)-1 - 亚硝基脲治疗后的肺纤维化
Chest. 1977 Sep;72(3):372-3. doi: 10.1378/chest.72.3.372.

引用本文的文献

1
Lung damage from cytotoxic drugs.细胞毒性药物所致的肺损伤。
Cancer Chemother Pharmacol. 1980;4(1):17-27. doi: 10.1007/BF00255453.

本文引用的文献

1
Triple combination chemotherapy of disseminated melanoma.播散性黑色素瘤的三联化疗
Cancer. 1972 Jun;29(6):1489-95. doi: 10.1002/1097-0142(197206)29:6<1489::aid-cncr2820290612>3.0.co;2-4.
2
The spectrum of drug-induced pulmonary disease.药物性肺疾病的谱
Ann Intern Med. 1972 Dec;77(6):977-91. doi: 10.7326/0003-4819-77-6-977.
3
[Treatment of metastasising melanoma with a combination of cytostatic agents (author's transl)].用细胞抑制剂联合治疗转移性黑色素瘤(作者译)
Dtsch Med Wochenschr. 1976 Jun 4;101(23):890-4. doi: 10.1055/s-0028-1104136.
4
Remission maintenance of acute nonlymphoblastic leukemia with BCNU (NSC-409962) and cyclophosphamide (NSC-26271).
Cancer Chemother Rep. 1975 May-Jun;59(3):537-45.
5
Pulmonary toxicity in long-term administration of BCNU.长期使用卡氮芥的肺部毒性。
Cancer Treat Rep. 1976 Nov;60(11):1691-4.